← Back to Analyst Consensus 
TECX Buy
Tectonic Therapeutic, Inc.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 1 upgrades / ▼ 0 downgrades / 0 reiterations from 1 firms
Next Earnings
Nov 5, 2026 (9 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 12, 2026 | UBS | initiate | — → Neutral | — | 54% |
| Aug 7, 2026 | Wells Fargo | maintain | Overweight → Overweight | — | 54% |
| May 26, 2026 | Raymond James | upgrade | Outperform → Strong Buy | — | 54% |
| Apr 14, 2026 | Stifel | initiate | — → Buy | — | 54% |
| Jan 8, 2026 | Truist Securities | maintain | Buy → Buy | $60 | 55% |
| Sep 3, 2025 | Oppenheimer | initiate | — → Outperform | $80 | 52% |
| Jul 21, 2025 | Truist Securities | initiate | — → Buy | $64 | 55% |
| Jun 6, 2025 | LifeSci Capital | initiate | — → Outperform | $87 | 55% |
| May 15, 2025 | Mizuho | maintain | Outperform → Outperform | $85 | 52% |
| Apr 21, 2025 | Mizuho | initiate | — → Outperform | $51 | 52% |
| Mar 21, 2025 | Wells Fargo | maintain | Overweight → Overweight | $101 | 54% |
| Jan 31, 2025 | Wells Fargo | maintain | Overweight → Overweight | $112 | 54% |
| Nov 20, 2024 | Raymond James | initiate | — → Outperform | $65 | 54% |
| Nov 12, 2024 | Wells Fargo | maintain | Overweight → Overweight | $79 | 54% |
| Nov 11, 2024 | Leerink Partners | maintain | Outperform → Outperform | $69 | 51% |
| Aug 22, 2024 | Wells Fargo | initiate | — → Overweight | $55 | 54% |
| Jul 24, 2024 | Leerink Partners | initiate | — → Outperform | $49 | 51% |
| Jun 26, 2024 | Piper Sandler | initiate | — → Overweight | $76 | 54% |
| Jun 24, 2024 | TD Cowen | initiate | — → Buy | $0 | 54% |
Price Target Trend
May 13, 2026 Oct 27, 2026
EPS Estimates
+1y —
0y —
+1q —
0q —
Cross-Platform Signals
No cross-platform signals in the last 90 days